Drug-Induced TdP Risk Assessment (Q4834866): Difference between revisions
From MaRDI portal
Changed claim: publication date (P28): 27 July 2020 |
Removed claim: author (P16): Oleksandr Zadorozhnyi (Q2325377) |
||
| (One intermediate revision by one other user not shown) | |||
| Property / author | |||
| Property / author: Oleksandr Zadorozhnyi / rank | |||
| Property / author: Oleksandr Zadorozhnyi / qualifier | |||
| Property / community | |||
| Property / community: MaRDI / rank | |||
Latest revision as of 11:29, 18 April 2025
Dataset in the Graphical Modelling and Causal Inference Zenodo Community
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Drug-Induced TdP Risk Assessment |
Dataset in the Graphical Modelling and Causal Inference Zenodo Community |
Statements
27 July 2020
0 references
A manually collected dataset that investigates the proarrhythmic risk of 109 drugs using parameters obtained from biophysical models. The dataset provides 4 torsade de pointes (TdP) risk categories. For all 109 drugs, IC50 values and Hill coefficients (h) for INa, INaL, IKr, Ito, ICaL, IK1, and IKs and human effective free therapeutic plasma concentration (EFTPC) were obtained (Llopis-Lorente et al., 2020).
0 references
